Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jared M. Weiss"'
Autor:
Aaron D. Falchook, MD, Gregg Tracton, BS, Lori Stravers, MPH, CHES, Mary E. Fleming, ANP, Anna C. Snavely, PhD, Jeanne F. Noe, PharmD, David N. Hayes, MD, MPH, Juneko E. Grilley-Olson, MD, Jared M. Weiss, MD, Bryce B. Reeve, PhD, Ethan M. Basch, MD, Bhishamjit S. Chera, MD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 2, Pp 115-121 (2016)
Purpose: Accurate assessment of toxicity allows for timely delivery of supportive measures during radiation therapy for head and neck cancer. The current paradigm requires weekly evaluation of patients by a provider. The purpose of this study is to e
Externí odkaz:
https://doaj.org/article/f6a9d2db252b408daed25d3320aeb23d
Autor:
Zhao Yang, Taofeek K Owonikoko, Konstantin H Dragnev, Anne Y Lai, Jessica A Sorrentino, Jared M Weiss, Julie A Rytlewski, Jill Hood, Rajesh K Malik, Jay C Strum, Patrick J Roberts
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Combination treatment with chemotherapy and immune checkpoint inhibitors (ICIs) has demonstrated meaningful clinical benefit to patients. However, chemotherapy-induced damage to the immune system can potentially diminish the efficacy of ch
Externí odkaz:
https://doaj.org/article/69e813bd7bb34caeaa699ef0d1860007
Autor:
Alexander T. Murr, Nicholas R. Lenze, Jared M. Weiss, Juneko E. Grilley‐Olson, Shetal A. Patel, Colette Shen, Bhishamjit S. Chera, Adam M. Zanation, Brian D. Thorp, Siddharth H. Sheth
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 167(5)
To compare oncologic outcomes in sinonasal squamous cell carcinoma (SNSCC) treated with standard of care (SOC) definitive therapy, consisting of surgery or chemoradiotherapy, vs induction therapy followed by definitive therapy.Retrospective review.Ac
Autor:
Jared M, Weiss, Stephen, Bagley, Wei-Ting, Hwang, Joshua, Bauml, Juneko Grilley, Olson, Roger B, Cohen, David Neil, Hayes, Corey, Langer
Publikováno v:
Cancer. 122(15)
The combination of cisplatin, 5-fluorouracil, and cetuximab is a standard treatment for patients with recurrent/metastatic head and neck cancer, with a high rate of toxicity. Identifying less toxic, equally effective regimens is imperative. Therefore